MT: Delivery Strategies
gene regulation
miRNA delivery
non-viral RNA vector
trans-amplifying RNA
trans-replication
Journal
Molecular therapy. Nucleic acids
ISSN: 2162-2531
Titre abrégé: Mol Ther Nucleic Acids
Pays: United States
ID NLM: 101581621
Informations de publication
Date de publication:
11 Jun 2024
11 Jun 2024
Historique:
received:
31
08
2023
accepted:
28
02
2024
medline:
28
3
2024
pubmed:
28
3
2024
entrez:
28
3
2024
Statut:
epublish
Résumé
The co-delivery of microRNAs (miRNAs) and protein-coding RNA presents an opportunity for a combined approach to gene expression and gene regulation for therapeutic applications. Protein delivery is established using long mRNA, self-, and
Identifiants
pubmed: 38545619
doi: 10.1016/j.omtn.2024.102162
pii: S2162-2531(24)00049-0
pmc: PMC10965815
doi:
Types de publication
Journal Article
Langues
eng
Pagination
102162Informations de copyright
© 2024 The Authors.
Déclaration de conflit d'intérêts
U.S., T.B., and A.Y. are inventors on patents and patent applications that cover parts of this article. U.S. is a management board member and employee and has securities from BioNTech SE, a company developing therapeutic RNA.